- Home
- KALA vs OPAD Comparison
KALA vs OPAD Comparison
Compare KALA & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- OPAD
- Stock Information
- Founded
- KALA 2009
- OPAD 2015
- Country
- KALA United States
- OPAD United States
- Employees
- KALA N/A
- OPAD N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- KALA Health Care
- OPAD Finance
- Exchange
- KALA Nasdaq
- OPAD Nasdaq
- Market Cap
- KALA 26.2M
- OPAD 25.3M
- IPO Year
- KALA 2017
- OPAD N/A
- Fundamental
- Price
- KALA $5.86
- OPAD $1.39
- Analyst Decision
- KALA Strong Buy
- OPAD Hold
- Analyst Count
- KALA 3
- OPAD 5
- Target Price
- KALA $14.00
- OPAD $2.38
- AVG Volume (30 Days)
- KALA 123.2K
- OPAD 142.8K
- Earning Date
- KALA 08-05-2025
- OPAD 08-04-2025
- Dividend Yield
- KALA N/A
- OPAD N/A
- EPS Growth
- KALA N/A
- OPAD N/A
- EPS
- KALA N/A
- OPAD N/A
- Revenue
- KALA N/A
- OPAD $794,159,000.00
- Revenue This Year
- KALA N/A
- OPAD N/A
- Revenue Next Year
- KALA N/A
- OPAD $40.79
- P/E Ratio
- KALA N/A
- OPAD N/A
- Revenue Growth
- KALA N/A
- OPAD N/A
- 52 Week Low
- KALA $2.92
- OPAD $0.91
- 52 Week High
- KALA $11.20
- OPAD $5.13
- Technical
- Relative Strength Index (RSI)
- KALA 60.68
- OPAD 70.23
- Support Level
- KALA $4.36
- OPAD $0.91
- Resistance Level
- KALA $7.00
- OPAD $1.59
- Average True Range (ATR)
- KALA 0.71
- OPAD 0.13
- MACD
- KALA 0.16
- OPAD 0.06
- Stochastic Oscillator
- KALA 63.97
- OPAD 77.94
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.